Tumour pO2 can be increased markedly by mild hyperthermia

Area of Science:

• Oncology
• Medical Physics
• Preclinical Cancer Research

Background:

• Tumor hypoxia is a significant challenge in cancer treatment, often leading to radioresistance and poor therapeutic outcomes.
• Hyperthermia, the application of heat, has shown potential in improving cancer treatment efficacy, but its application at modest temperatures needs further investigation.

Purpose of the Study:

• To investigate the feasibility of improving tumor oxygenation using hyperthermia at modest, clinically achievable temperatures.
• To evaluate the impact of modest temperature hyperthermia (MTH) on tumor partial pressure of oxygen (pO2) in preclinical models.

Main Methods:

• FSaII tumors in C3H mice and R3230 AC tumors in Fischer rats were used as preclinical models.
• Tumors were heated using a water bath at specific temperatures and durations (e.g., 41.5°C for 1 hour, 42.5°C for 30 minutes).
• Tumor pO2 was measured using an Eppendorf pO2 histograph before and after hyperthermia treatment.

Main Results:

• Median pO2 in FSaII tumors increased from 6.5 mmHg to 16.6 mmHg after heating at 41.5°C for 1 hour.
• Median pO2 in R3230 AC tumors increased from 3.7 mmHg to 12.2 mmHg after heating at 42.5°C for 30 minutes.
• Improved tumor oxygenation was sustained for at least 24 hours post-heating, and the frequency of severe hypoxia (<5 mmHg) decreased markedly.

Conclusions:

• Modest temperature hyperthermia is a feasible method for improving tumor oxygenation in preclinical settings.
• MTH demonstrates potential as an effective and clinically applicable strategy to enhance oxygen levels within tumors, possibly improving treatment outcomes.